AMED vs MSFT: Which Stock is Better?
Side-by-side comparison of Amedisys Inc and Microsoft Corp in 2026
AMED
Amedisys Inc
—
MSFT
Microsoft Corp
$396.65
Key Metrics Comparison
| Metric | AMED | MSFT | Winner |
|---|---|---|---|
| Market Cap | $3.32B | N/A | AMED |
| P/E Ratio | 39.30 | 24.57 | MSFT |
| EPS (TTM) | $2.57 | $16.00 | MSFT |
| Revenue Growth | 0.1% | 0.2% | MSFT |
| Gross Margin | 43.2% | 68.6% | MSFT |
Analyze AMED
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is AMED or MSFT a better investment?
Comparing AMED and MSFT: Amedisys Inc has a market cap of $3.32B while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between AMED and MSFT?
AMED (Amedisys Inc) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: AMED or MSFT?
Based on P/E ratios, MSFT trades at a lower multiple (24.6x vs 39.3x).
Which is growing faster: AMED or MSFT?
MSFT has higher revenue growth at 0.2% vs 0.1% for AMED.
Which company is more profitable: AMED or MSFT?
Microsoft Corp (MSFT) has higher gross margins at 68.6% compared to 43.2% for AMED.
Which is the larger company: AMED or MSFT?
Amedisys Inc (AMED) is larger with a market cap of $3.32B compared to N/A for MSFT.
Should I buy AMED or MSFT in 2026?
Both AMED and MSFT have investment merit. AMED trades at $N/A while MSFT trades at $396.65. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between AMED and MSFT stock?
Key differences: Market Cap ($3.32B vs N/A), P/E Ratio (39.3x vs 24.6x), Revenue Growth (0.1% vs 0.2%), Gross Margin (43.2% vs 68.6%).